Publications by authors named "Chris Edlin"

Claim this Profile
A
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites.
Shaowei Zhang, Michiyo Sakuma, Girdhar S Deora, Colin W Levy, Alex Klausing, Chris D Edlin

Commun Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and In-Vitro ADME Assessment of a Series of Novel Anti-Malarial Agents Suitable for Hit-to-Lead Chemistry.
Chris D Edlin, Garreth Morgans, Susan Winks, Sandra Duffy, Vicky M Avery

ACS Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of patent sharing in neglected disease drug discovery.
Chris Edlin

Future Med Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
Charlotte J Mitchell, Stuart P Ballantine, Diane M Coe, Caroline M Cook, Christopher J Delves, Chris D Edlin

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of unprotected and borane-protected cyclic phosphines using Ru- and Mo- based olefin metathesis catalysts.
Catherine A Slinn, Alison J Redgrave, S Lucy Hind, Chris Edlin, Steven P Nolan

Org Biomol Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis